Ok. Putting all the verbal back and forth bullshit aside, what do you think investors are missing? Using currently known numbers, imun should be worth about $30/share. Why do you think it trades around $5?
Assumptions:
Current market of new company: $200,000,000
Cyto owns more than 50% so use: $100,000,000
Imun owns 15% of cyto shares so? $15,000,000
Divided by 487,000 imun shares: $30/share
So what's the missing piece of the puzzle?
News 
Market Data 
Discover 
